Endocrinologist News and Research

RSS

Scientists identify new gene that contributes to type 1 diabetes progression

When the pro-inflammatory pair, a receptor called CCR2 and its ligand CCL-2, get together, it increases the risk of developing type 1 diabetes, scientists report.

16 Nov 2021

Expert to focus on the wonder of hormones that control energy balance and metabolism

An exploration of the beauty and wonder of the hormones that control our energy balance and metabolism and how they can be replaced and manipulated to improve human health will be the focus of a lecture celebrating the centenary of insulin by Professor Sir Stephen O'Rahilly at the Royal Society of Medicine on Thursday 2 December 2021.

15 Nov 2021

New project to deploy AI technology for detecting sight-threatening diabetic eye disease

St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust are leading a half a million pound project on artificial intelligence (AI), funded by NHSX and the Health Foundation, and enabled by the National Institute for Health Research.

22 Oct 2021

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.

19 Oct 2021

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

In one of the largest and most racially diverse studies to date of American children and adolescents with type 1 and type 2 diabetes, researchers at Johns Hopkins Medicine, Baylor College of Medicine and the University of Wisconsin have identified the clinical and demographic factors associated with pediatric diabetic retinopathy.

7 Oct 2021

Aging produces significant changes in the gut microbiome

Researchers at Cedars-Sinai have found that aging produces significant changes in the microbiome of the human small intestine distinct from those caused by medications or illness burden. The findings have been published in the journal Cell Reports.

3 Oct 2021

JDRF announces new grant to explore methods to alleviate diabetes distress

JDRF, the leading global nonprofit funder of type 1 diabetes (T1D) research, announces a new grant awarded to Albert Einstein College of Medicine and Montefiore Health System. Led by endocrinologist Shivani Agarwal, M.D., M.P.H., and by psychologist Jeffrey Gonzalez, Ph.D., the study will utilize telemedicine to deliver cognitive behavioral therapy to young adults with T1D to reduce diabetes-related distress.

30 Sep 2021

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes, according to researchers at Penn State College of Medicine.

27 Sep 2021

Carbohydrate-insulin model can better explain obesity and weight gain

Statistics from the Centers for Disease Control and Prevention (CDC) show that obesity affects more than 40% of American adults, placing them at higher risk for heart disease, stroke, type 2 diabetes, and certain types of cancer.

13 Sep 2021

Study describes associations between gender-affirming hormone therapy and body weight changes

Gender-affirming hormone therapy is the bedrock of medical therapy for many transgender and gender diverse individuals. Some adult transgender individuals decide with their health care provider to start hormone therapy – testosterone for transmasculine people and generally a combination of estrogen and antiandrogens for transfeminine people – specifically for the physical and psychological effects these hormones produce, including changes to the voice, skin, facial and body hair and body composition. However, in the context of the global obesity epidemic, little is known about obesity rates and weight changes in adults treated with gender-affirming hormone therapy.

20 Aug 2021

Study reveals how high dietary fructose increases rates of obesity and cancers

Eating fructose appears to alter cells in the digestive tract in a way that enables it to take in more nutrients, according to a preclinical study from investigators at Weill Cornell Medicine and NewYork-Presbyterian.

18 Aug 2021

$Cognitive decline increases future fracture risk in women$

Cognitive decline increases future fracture risk in women

Researchers led by the Garvan Institute of Medical Research have discovered a link between cognitive decline and a faster rate of bone loss, and found that cognitive decline over five years increased future fracture risk in women. The association between cognitive decline and bone loss was weaker in men.

21 Jul 2021

Transgender and gender diverse youth need high-quality medical care just as other teenagers

The Endocrine Society and a coalition of LGBTQ+ youth and reproductive health organizations argued in a joint submission to the High Court of England and Wales that transgender teenagers should be able to give informed consent to treatment the same way teenagers with other medical conditions can.

22 Jun 2021

High proportion of people with diabetes have chronic kidney disease, research reveals

Some 42% of patients attending a dedicated diabetes clinic have signs of established chronic kidney disease, the first detailed research of its kind in Ireland has revealed.

14 Jun 2021

Potential leptin therapy for nonalcoholic steatohepatitis

In those with fatty liver disease, a person's fat goes to their liver instead of their fat tissue, either because of an absence of fat depots, which is seen in the rare genetic disease lipodystrophy, or because the depots are too full, which is seen in people with obesity.

7 Jun 2021

Little-known illnesses turning up in Covid long-haulers

The day Dr. Elizabeth Dawson was diagnosed with covid-19 in October, she awoke feeling as if she had a bad hangover. Four months later she tested negative for the virus, but her symptoms have only worsened.

1 Jun 2021

Men with low testosterone levels are more susceptible to severe COVID-19

Throughout the pandemic, doctors have seen evidence that men with COVID-19 fare worse, on average, than women with the infection.

25 May 2021

Study highlights the need for more personalized approach to measuring BMI

The results of an extensive new study funded by the National Institute for Health Research (NIHR), Ethnic-specific BMI cut-off points for obesity based on type 2 diabetes mellitus risk: a cohort study of 1.5 million people in England, presented at this year’s European Congress on Obesity (ECO) and published simultaneously in the leading journal, The Lancet Diabetes & Endocrinology reveal that inaccurate and outdated interpretations of the standard Body Mass Index (BMI) values for patients from BAME backgrounds in England could potentially be putting their health at risk.

17 May 2021

Immunome could provide unprecedented insight into an individual’s health

The human immune system doesn't just protect our health, it reflects it. Each encounter with a potential disease-causing agent causes the body to produce specific immune agents -- proteins known as antibodies and T-cell receptors -- tailor-made to recognize and destroy the invader.

5 May 2021

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur.

26 Apr 2021